Viewed through the eyes of an innovation manager, quantum dot technology could either represent the best thing since sliced bread or your darkest nightmare. Quantum dots enable applications ranging from large screen televisions to packaging to medical diagnosis and imaging. Quantum dots have the potential to disrupt the status quo across virtually all industrial sectors. Your product may be obsolete and you just don’t know it yet!
Founded as a NASA JV to help companies harness the tremendous IT and IP from the Apollo Program, we’ve helped organizations affect high-impact innovation collaborations ever since. Click here to see ways Nerac can help you affect collaborative SDG strategies, ecosystems and ICT-enabled innovations for new “giant leaps” that benefit mankind and shareholders alike.
While clinical data is required for manufacturers of high risk devices and implants, the vast majority of manufacturers that make low-to-medium risk devices may not need to conduct clinical trials for their products or produce peer-reviewed literature that supports their clinical use. This article helps identify the specific clauses of the guidance document that pertain to clinical data and explores alternative pathways to compliance.